Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmaEssentia and AOP Orphan Receive Positive CHMP Opinion For Besremi(™) (Ropeginterferon alfa-2b) For Treatment Of Polycythemia Vera (PV) In EU 2018-12-17 16:00
PharmaEssentia Updates Progress of Ropeginterferon Alfa-2b Clinical Program 2018-12-05 19:00
PharmaEssentia Announces Favorable Two-year Results of Ropeginterferon Alfa-2b in Polycythemia Vera at the American Society of Hematology (ASH) Annual Meeting 2017 2017-12-11 13:04
1